katavrga Posted January 10, 2021 Share Posted January 10, 2021 Dear Members. Maybe this was already discussed here, I'm not shure... My mom aged 60 was diagnosed two years ago with SCLC limited stage (well, barely limited, with limphnode involvement on the other side of the lungs), so underwent carboplatin+etoposide and radiation therapy and was in remission until 5 days ago. A local recurrance of about 2 cm appeared on CT scan and her oncologyst (a great guy by the way) offerd her the chance to enroll in the RESILIENT study for liposomal irinotecan vs topotecan (standard 2nd line therapy in Romania). So here we are, full of questions and so few anwsers, but the most important one would be: is a progression free period (how short it may be) possible after 2nd line therapy or 2nd therapy is only use to limit/slow down the advance of the disease? Thank you all for your thoughts and please don't mind my written English (my spoken one is worse :)) Kata jack14 1 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.